Moderna Vaccine 96 Per Cent Effective In 12-17 Year-Olds, Study Shows.

Moderna Vaccine 96 Per Cent Effective In 12-17 Year-Olds, Study Shows

The study "showed vaccine efficacy against COVID-19 of 96%", the company said. (File)

Washington:

Moderna said Thursday its Covid-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.

Two-thirds of the 3,235 participants in trials in the United States received the vaccine and one-third were given a placebo.

The study "showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identified to date," the company said.

Tests detected 12 cases of coronavirus 14 days after the first shot. For these intermediate results, participants were followed up on average 35 days after the second injection.

The pharmaceutical company said that any side effects had been "mild or moderate in severity," most commonly pain at the injection site. With the second shot, side effects included "headache, fatigue, myalgia and chills," similar to those observed in adults who had received the vaccine.

"No serious safety concerns have been identified to date," it said.

Moderna said it is currently "in discussions with regulators about a potential amendment to its regulatory filings" to authorize the vaccine for this age group. It is currently only certified for people aged 18 and over in countries where it has already been approved.

Pfizer and BioNTech have already applied for authorization of their own vaccine for 12-15 year olds in the United States and Europe. On Wednesday, Canada became the first country to authorize the Pfizer shot for this age group.

The vaccination of teens is the next step in the campaign to eventually contain the epidemic. Moderna also began trials of its vaccine in children aged six months to 11 years in March.

Pfizer and BioNTech announced on Tuesday that they hope to file an emergency authorization request for their vaccine for children aged two to 11 in September in the United States.

Pfizer CEO Albert Bourla said the company could apply for authorization to inoculate children aged between from 6 months and two years "in the fourth quarter."

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Related news
Fruit Vendors Feed 1,000 Hungry Monkeys Amid Lockdown in India.

Fruit Vendors Feed 1,000 Hungry Monkeys Amid Lockdown in India.

Fruit vendors in India's southern Tamil Nadu state are comforting about 1,000 hungry monkeys at a temple there by feeding them during the ongoing lockdown imposed to curb the spread of coronavirus. As the famous Thiruparankundram Murugan Temple in...

Royals launch charm offensive at G7 summit

Royals launch charm offensive at G7 summit

The Queen was joined by senior members of the Royal Family as they aimed to boost Britain's profile on the world stage. SUBSCRIBE to our YouTube channel for more videos: Follow us on Twitter: Like us on Facebook: Follow us on Instagram: For more c...

Gutfeld: CNN becomes more 'racist' everyday, they are in freefall.

Gutfeld: CNN becomes more 'racist' everyday, they are in freefall.

'The Five' reacts to CNN host Brianna Keilar sparring with Rep. Byron Donalds over Congressional Black Caucus snub. #FoxNews #TheFive Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hou...

Press Preview: What’s making Saturday’s front pages?.

Press Preview: What’s making Saturday’s front pages?.

We take a look at what’s making the news on Saturday with Christina Lamb, the Sunday Times' chief foreign correspondent, and conservative commentator Tim Montgomerie. SUBSCRIBE to our YouTube channel for more videos: Follow us on Twitter: Like us ...

G7: Calls for increased global vaccine effort

G7: Calls for increased global vaccine effort

A global effort to beat COVID has been central to the G7 so far but charities have warned not enough is being done. SUBSCRIBE to our YouTube channel for more videos: Follow us on Twitter: Like us on Facebook: Follow us on Instagram: For more conte...

Former NCAA swimmer Schuyler Bailar discusses attacks on transgender Americans' civil liberties.

Former NCAA swimmer Schuyler Bailar discusses attacks on transgender Americans' civil liberties.

Schuyler Bailar, the first transgender NCAA D1 men’s athlete, joined CBSN to discuss the attacks on transgender Americans' civil liberties as more states pursue of anti-LGBTQ legislation. CBSN is CBS News’ 24/7 digital streaming news service featu...